These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8137297

  • 1. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, Barbanti-Brodano G, Croce CM.
    Cancer Res; 1994 Apr 01; 54(7):1818-24. PubMed ID: 8137297
    [Abstract] [Full Text] [Related]

  • 2. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ.
    Oncogene; 1991 Oct 01; 6(10):1791-7. PubMed ID: 1923504
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 4. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW.
    Cancer Res; 1994 Apr 01; 54(7):1791-4. PubMed ID: 7511052
    [Abstract] [Full Text] [Related]

  • 5. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
    Theile M, Hartmann S, Scherthan H, Arnold W, Deppert W, Frege R, Glaab F, Haensch W, Scherneck S.
    Oncogene; 1995 Feb 02; 10(3):439-47. PubMed ID: 7845668
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.
    Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brodano G, Croce CM.
    Cancer Res; 1994 Mar 01; 54(5):1331-6. PubMed ID: 8118824
    [Abstract] [Full Text] [Related]

  • 8. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.
    Cajot JF, Anderson MJ, Lehman TA, Shapiro H, Briggs AA, Stanbridge EJ.
    Cancer Res; 1992 Dec 15; 52(24):6956-60. PubMed ID: 1458487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.
    Plummer SJ, Adams L, Simmons JA, Casey G.
    Oncogene; 1997 May 15; 14(19):2339-45. PubMed ID: 9178910
    [Abstract] [Full Text] [Related]

  • 11. Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11.
    Negrini M, Castagnoli A, Sabbioni S, Recanatini E, Giovannini G, Possati L, Stanbridge EJ, Nenci I, Barbanti-Brodano G.
    Oncogene; 1992 Oct 15; 7(10):2013-8. PubMed ID: 1408142
    [Abstract] [Full Text] [Related]

  • 12. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons.
    Balcer-Kubiczek EK, Yin J, Lin K, Harrison GH, Abraham JM, Meltzer SJ.
    Radiat Res; 1995 Jun 15; 142(3):256-62. PubMed ID: 7761574
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
    Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan KH, Seth P.
    Clin Cancer Res; 1995 Aug 15; 1(8):889-97. PubMed ID: 9816059
    [Abstract] [Full Text] [Related]

  • 14. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P, Bazar K, Huper G, Lozano G, Marks J, Iglehart JD.
    Oncogene; 1996 Sep 19; 13(6):1315-22. PubMed ID: 8808706
    [Abstract] [Full Text] [Related]

  • 15. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B, Safa AR.
    Oncogene; 1997 Jan 30; 14(4):499-506. PubMed ID: 9053847
    [Abstract] [Full Text] [Related]

  • 16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 30; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 17. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA, Lupu R.
    Int J Mol Med; 2005 Jan 30; 15(1):33-40. PubMed ID: 15583825
    [Abstract] [Full Text] [Related]

  • 18. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
    Runnebaum IB, Yee JK, Kieback DG, Sukumar S, Friedmann T.
    Anticancer Res; 1994 Jan 30; 14(3A):1137-44. PubMed ID: 8074464
    [Abstract] [Full Text] [Related]

  • 19. p53 mutation and tamoxifen resistance in breast cancer.
    Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L.
    Clin Cancer Res; 1995 Oct 30; 1(10):1203-8. PubMed ID: 9815913
    [Abstract] [Full Text] [Related]

  • 20. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H, Lai B, Li J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May 30; 21(5):268-72. PubMed ID: 11326947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.